Hispidin, a phenolic compound from Phellinus linteus (a medicinal mushroom), has been shown to possess strong
anti-oxidant, anti-
cancer, anti-diabetic, and anti-
dementia properties. However, the cardioprotective efficacy of
hispidin has not yet been investigated. In the present study, we investigated the protective effect of
hispidin against oxidative stress-induced apoptosis in H9c2 cardiomyoblast cells and neonatal rat ventricular myocytes. While the treatment of H9c2 cardiomyoblast cells with
hydrogen peroxide caused a loss of cell viability and an increase in the number of apoptotic cells,
hispidin significantly protected the cells against
hydrogen peroxide-induced cell death without any cytotoxicity as determined by XTT assay, LDH release assay,
Hoechst 33342 assay, and Western blotting of apoptosis
proteins such as
caspase-3, Bax, and Bcl-2. Our data also shows that
hispidin significantly scavenged intracellular ROS, and markedly enhanced the expression of
antioxidant enzymes such as
heme oxygenase-1 and
catalase, which was accompanied by the concomitant activation of Akt/GSK-3β and ERK1/2 phosphorylation in H9c2 cardiomyoblast cells. The effects of
hispidin on Akt and ERK phosphorylation were abrogated by
LY294002 (a PI3K/Akt inhibitor) and
U0126 (an ERK1/2 inhibitor). The effect of
hispidin on GSK-3b activities was also blocked by
LY294002. Furthermore, inhibiting the Akt/GSK-3β and ERK1/2 pathway by these inhibitors significantly reversed the
hispidin-induced Bax and Bcl-2 expression, apoptosis induction, and ROS production. These findings indicate that
hispidin protects against apoptosis in H9c2 cardiomyoblast cells exposed to
hydrogen peroxide through reducing intracellular ROS production, regulating apoptosis-related
proteins, and the activation of the Akt/GSK-3β and ERK1/2 signaling pathways.